tiprankstipranks

Rafael Amado Insider Profile

4 Followers
Rafael Amado, President, R&D at Adaptimmune Therapeutics, holds 20.42K shares in Zai Lab (Ticker: ZLAB), holds 58.95K shares in Poseida Therapeutics (Ticker: PSTX), holds 541.95K shares in Allogene Therapeutics (Ticker: ALLO).
tipranks
Rafael Amado

Rafael Amado
Adaptimmune Therapeutics (ADAP)
President, R&D

Not Ranked
Rafael Amado has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
62.18%
28.53%
8.69%
0.60%
A breakdown of Rafael Amado's holdings

Insider Roles

Allogene Therapeutics
(ALLO)
EVP of R&D
Zai Lab
(ZLAB)
President, Head of Global Oncology Research and Development
Poseida Therapeutics
(PSTX)
Director
Adaptimmune Therapeutics
(ADAP)
President, R&D
Roles that Rafael Amado holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Rafael Amado

Rafael Amado's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Adaptimmune Therapeutics
Aug 07, 2019
President, R&D
Uninformative Sell
22.75K
$10.96K
Allogene Therapeutics
Oct 11, 2022
EVP of R&D
Uninformative Buy
$1.14M
Zai Lab
Aug 14, 2024
President, Head of Global Oncology Research and Development
Uninformative Sell
50.46K
$524.72K
Poseida Therapeutics
Jun 18, 2024
Director
Uninformative Buy
$159.75K
List of latest transactions for each holding click on a transaction to see Rafael Amado's performance on stock

Rafael Amado insider profile FAQ

What is the percentage of profitable transactions made by Rafael Amado?
The percentage of profitable transactions made by Rafael Amado is ―.
    What is the average return per transaction made by Rafael Amado?
    The average return per transaction made by Rafael Amado is ―.
      What stocks does Rafael Amado hold?
      Rafael Amado holds: ADAP, ALLO, ZLAB, PSTX stocks.
        What was Rafael Amado’s latest transaction?
        Rafael Amado latest transaction was an Uninformative Sell of $50.46K.
          What was Rafael Amado's most profitable transaction?
          Rafael Amado’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Rafael Amado's role in Adaptimmune Therapeutics?
            Rafael Amado's role in Adaptimmune Therapeutics is President, R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.